Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer
- PMID: 175945
Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer
Abstract
The central theme of this communication is the interaction of herpes simplex virus type 2 with its host. In addition to the productive infection, we are confronted by latency and, as suggested by recent studies, by cancer. The possible mechanisms of latency and the role it may play as a precursor of carcinogenesis are discussed. If virus is to coexist with its host, a defined level of molecular interaction between host and viral gene products must exist. The association of AG-4 with active tumor growth and its identification as a minor virion protein, also exposed on the surface of the infected cell, open new vistas in the understanding of the role virus-host cell interactions may play in tumor growth. The modulation of the host immune response by the results of this interaction may play a significant role in cancer control. In these terms, the observation that antibody to AG-4 is a macroglobulin and that, therefore, immunity to AG-4 may be T-cell independent, should be given further consideration.
Similar articles
-
Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer.Cancer. 1977 Apr;39(4 Suppl):1834-49. doi: 10.1002/1097-0142(197704)39:4+<1834::aid-cncr2820390816>3.0.co;2-l. Cancer. 1977. PMID: 192436 Review.
-
Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.Cancer Res. 1976 Dec;36(12):4394-401. Cancer Res. 1976. PMID: 187320
-
The role of herpes simplex virus in cervical and vulvar cancer.Dev Biol Stand. 1982;52:87-94. Dev Biol Stand. 1982. PMID: 6299862
-
Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.Biomedicine. 1975 Nov 10;23(9):399-401. Biomedicine. 1975. PMID: 182294 No abstract available.
-
Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.J Obstet Gynaecol Res. 2007 Apr;33(2):103-13. doi: 10.1111/j.1447-0756.2007.00492.x. J Obstet Gynaecol Res. 2007. PMID: 17441881 Review.
Cited by
-
Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera.Infect Immun. 1981 Mar;31(3):1062-70. doi: 10.1128/iai.31.3.1062-1070.1981. Infect Immun. 1981. PMID: 6262247 Free PMC article.
-
Genital herpes and cervical carcinoma.Br Med J. 1978 Apr 1;1(6116):807. Br Med J. 1978. PMID: 638460 Free PMC article. No abstract available.
-
Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.Infect Immun. 1977 Jun;16(3):955-60. doi: 10.1128/iai.16.3.955-960.1977. Infect Immun. 1977. PMID: 197013 Free PMC article.
-
The association of viruses with urveal melanoma.Trans Am Ophthalmol Soc. 1979;77:367-421. Trans Am Ophthalmol Soc. 1979. PMID: 545833 Free PMC article.
-
Products of gynaecological neoplasms: clinical and pathological applications.Arch Gynecol. 1980;229(4):311-23. doi: 10.1007/BF02108582. Arch Gynecol. 1980. PMID: 6158296